Trademark Overview
On Saturday, May 9, 2026, a trademark application was filed for HYGTIA with the United States Patent and Trademark Office. The USPTO has given the HYGTIA trademark a serial number of 99813335. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Saturday, May 9, 2026. This trademark is owned by Hygtia Therapeutics Co., Ltd.. The HYGTIA trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Biological research; Scientific research in the nature of conducting clinical trials for others; Medical research; Research and development services in the field of antibodies; Medical and scientific research in the field of cancer treatment and diagnosis; Research and development services in the field of immunology; Pharmaceutical research services; Toxicology research services; Biotechnology research; Research and development services in the field of pharmaceutical preparations
Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Disinfectants; Chemical preparations for pharmaceutical or medical purposes, namely, for autoimmune and immune-mediated diseases, central nervous system (CNS) disorders, and inflammation-related diseases; Diagnostic reagents for medical use; Biological preparations for use in cell cultures for medical purposes; Biochemical reagents for medical or veterinary purposes; Vaccines; Dietary supplements for humans; Veterinary pharmaceutical preparations for the prevention of autoimmune and immune-mediated disorders in animals, inflammatory conditions in animals, and species-specific Indications
